A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...

Here is a detailed profile on Google DeepMind CEO Demis Hassabis, including details on his achivements and personal life.

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

That is the conclusion of the annual assessment of the sector's ability to attract financing by the BioIndustry Association ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

This week, Fortune published a magazine feature looking inside Demis Hassabis’s Isomorphic Labs.

The lack of initial public offerings (IPOs) also reflects a year of restricted growth. As per the BIA, no UK biotechs went ...

OpenAI is shifting its focus from monetising everyday ChatGPT prompts to building structural dependency through enterprise ...

Milwaukee Repertory Theater is opening its renovated studio theater with 'McNeal," from Pulitzer Prize winner and Brookfield ...

UK biotech had a difficult year in 2025. Funding was tighter, investors were hesitant, and deals took longer to ...

Demis Hassabis says the level of investment in some parts of the tech industry had become detached from commercial realities ...